Rising won has little effect on pharmaceutical sector

Companies focused on the domestic market, such as those in pharmaceutical and telecommunication sectors, remain largely unaffected by the changing exchange rate, industry sources said.

The sources added that pharmaceutical firms are more immune to the fluctuating rate as they import 80 percent of raw materials from China and India, so the strength of the won vis-a-vis the yuan and rupee are ...